159 related articles for article (PubMed ID: 2434524)
21. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal killer toxin-like antiidiotypic antibodies to control rat-pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
J Eukaryot Microbiol; 1997; 44(6):37S. PubMed ID: 9508425
[No Abstract] [Full Text] [Related]
23. Development and characterization of a monoclonal antibody against the tube precipitin antigen of Coccidioides immitis.
Dolan MJ; Cox RA; Williams V; Woolley S
Infect Immun; 1989 Apr; 57(4):1035-9. PubMed ID: 2494108
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci.
Conti S; Magliani W; Arseni S; Dieci E; Frazzi R; Salati A; Varaldo PE; Polonelli L
Mol Med; 2000 Jul; 6(7):613-9. PubMed ID: 10997342
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies and sandwich ELISA for quantitation of HM-1 killer toxin.
Komiyama T; Zhang QZ; Miyamoto M; Selvakumar D; Furuichi Y
Biol Pharm Bull; 2004 May; 27(5):691-3. PubMed ID: 15133246
[TBL] [Abstract][Full Text] [Related]
26. Production of yeast killer toxin in experimentally infected animals.
Polonelli L; Conti S; Gerloni M; Campani L; Mantovani MP; Morace G
Mycopathologia; 1990 Jun; 110(3):169-75. PubMed ID: 2201918
[TBL] [Abstract][Full Text] [Related]
27. Killer anti-idiotypes in the control of fungal infections.
Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
[TBL] [Abstract][Full Text] [Related]
28. In vitro leishmanicidal activity of a monoclonal antibody mimicking a yeast killer toxin.
Savoia D; Avanzini C; Conti S; Magliani V; Frazzi R; Polonelli L
J Eukaryot Microbiol; 2002; 49(4):319-23. PubMed ID: 12188222
[TBL] [Abstract][Full Text] [Related]
29. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
Polonelli L; De Bernardis F; Conti S; Boccanera M; Gerloni M; Morace G; Magliani W; Chezzi C; Cassone A
J Immunol; 1994 Mar; 152(6):3175-82. PubMed ID: 8144911
[TBL] [Abstract][Full Text] [Related]
30. Protective antifungal yeast killer toxin-like antibodies.
Magliani W; Conti S; Frazzi R; Ravanetti L; Maffei DL; Polonelli L
Curr Mol Med; 2005 Jun; 5(4):443-52. PubMed ID: 15978000
[TBL] [Abstract][Full Text] [Related]
31. Killer toxin from Hansenula mrakii selectively inhibits cell wall synthesis in a sensitive yeast.
Yamamoto T; Hiratani T; Hirata H; Imai M; Yamaguchi H
FEBS Lett; 1986 Mar; 197(1-2):50-4. PubMed ID: 3512308
[TBL] [Abstract][Full Text] [Related]
32. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies.
Polonelli L; Conti S; Gerloni M; Magliani W; Castagnola M; Morace G; Chezzi C
J Med Vet Mycol; 1991; 29(4):235-42. PubMed ID: 1941431
[TBL] [Abstract][Full Text] [Related]
33. Serotyping of fungal isolates by precipitating monoclonal antibodies.
Morace G; Amalfitano G; Polonelli L
Mycopathologia; 1986 Apr; 94(1):53-7. PubMed ID: 2425261
[TBL] [Abstract][Full Text] [Related]
34. Structure and activity of HYI killer toxin from Hansenula saturnus.
Komiyama T; Ohta T; Furuichi Y; Ohta Y; Tsukada Y
Biol Pharm Bull; 1995 Aug; 18(8):1057-9. PubMed ID: 8535395
[TBL] [Abstract][Full Text] [Related]
35. Killer factor interference in mixed opportunistic yeast cultures.
Conti S; Cantelli C; Gerloni M; Fisicaro P; Magliani W; Bertolotti D; Mozzoni P; Sullivan D; Coleman D; Polonelli L
Mycopathologia; 1996; 135(1):1-8. PubMed ID: 9008877
[TBL] [Abstract][Full Text] [Related]
36. Human natural yeast killer toxin-like candidacidal antibodies.
Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
[TBL] [Abstract][Full Text] [Related]
37. Specific and common antigenic determinants of Candida albicans isolates detected by monoclonal antibody.
Polonelli L; Morace G
J Clin Microbiol; 1986 Feb; 23(2):366-8. PubMed ID: 2422203
[TBL] [Abstract][Full Text] [Related]
38. Serological analysis of dermatophyte isolates with monoclonal antibodies produced against Microsporum canis.
Polonelli L; Morace G
J Clin Microbiol; 1985 Jan; 21(1):138-9. PubMed ID: 3918075
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterisation of monoclonal antibodies against hydrophobic membrane subunit 9 of the yeast mitochondrial H+-ATPase.
Jean-François MJ; Hertzog PJ; Marzuki S
Biochim Biophys Acta; 1988 Mar; 933(1):223-8. PubMed ID: 2450580
[TBL] [Abstract][Full Text] [Related]
40. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
